Jubilant Pharmova Ltd. - Research Center
530019 JUBLPHARMA Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Sales |
165.70 |
166.70 |
205.80 |
175.20 |
186.30 |
Operating profit |
-6.10 |
1.20 |
12.20 |
-0.70 |
0.80 |
Interest |
7.80 |
7.60 |
8.10 |
8.30 |
7.10 |
Gross profit |
29.90 |
13.10 |
54.20 |
10.00 |
12.10 |
EPS (Rs) |
0.66 |
-0.64 |
2.04 |
-0.15 |
-0.03 |
Quarterly
results in details
|
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Other income |
43.80 |
19.50 |
50.10 |
19.00 |
18.40 |
Stock adjustment |
-3.80 |
-5.00 |
19.30 |
-1.20 |
-10.30 |
Raw material |
62.20 |
65.50 |
74.10 |
69.10 |
94.90 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
51.40 |
48.70 |
46.50 |
49.90 |
46.10 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
62.00 |
56.30 |
53.70 |
58.10 |
54.80 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
13.30 |
13.10 |
12.70 |
12.30 |
11.90 |
Taxation |
6.10 |
-1.00 |
9.00 |
0.10 |
0.60 |
Net profit / loss |
10.50 |
-10.20 |
32.50 |
-2.40 |
-0.40 |
Extra ordinary item |
- |
-11.20 |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
15.90 |
15.90 |
15.90 |
15.90 |
15.90 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-3.68 |
0.72 |
5.93 |
-0.40 |
0.43 |
GPM (%) |
14.27 |
7.04 |
21.18 |
5.15 |
5.91 |
NPM (%) |
5.01 |
-5.48 |
12.70 |
-1.24 |
-0.20 |